ArticlePediatric dermatology
The Inpatient Burden of Pediatric Dermatology in the United States: A National Analysis of the 2022 Kids' Inpatient Database.
Article in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDermatologic conditions are a significant reason for pediatric hospitalizations in the United States. A prior analysis of the 2012 Kids' Inpatient Database (KID) established a national benchmark for this burden, but changes in medical coding, healthcare delivery, and demographics necessitate an updated assessment. This study aimed to quantify the current inpatient burden of pediatric dermatology and to identify associated demographic risk factors, financial costs, and mortality using a recent, nationally representative database.
methodsA cross-sectional study was conducted using the 2022 KID. Pediatric hospitalizations with a primary dermatology diagnosis (ICD-10-CM) were identified. Survey weights were used to generate national estimates of admission counts, costs, and mortality. Multivariable logistic regression was used to identify independent risk factors for a primary dermatology hospitalization.
resultsIn 2022, there were an estimated 29,766 pediatric dermatology hospitalizations, representing 2.3% of all pediatric admissions and a decline from 4.2% in 2012. These admissions generated a total national cost of $449.3 million. After adjusting for covariates, factors associated with higher odds of a dermatology admission included age 2-5 years (OR: 1.35; 95% CI: 1.21-1.52), Asian/Pacific Islander race (OR: 1.49; 95% CI: 1.32-1.69), Native American race (OR: 1.17; 95% CI: 1.00-1.36), Hispanic ethnicity (OR: 1.07; 95% CI: 1.01-1.14), lowest income quartile (OR: 1.06; 95% CI: 1.01-1.12), and Medicaid coverage (OR: 1.09; 95% CI: 1.04-1.14). Female sex was associated with lower odds (OR: 0.95; 95% CI: 0.92-0.98). In-hospital mortality was 0.1%.
conclusionThe national burden of inpatient pediatric dermatology has decreased over the past decade. However, significant disparities related to socioeconomic status and race/ethnicity persist and have evolved. These findings underscore the continued need for interventions aimed at improving access to outpatient dermatologic care for underserved pediatric populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.